EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Oropouche Virus (OROV) Vaccine Development for Vulnerable Populations: Epidemiological Context, Challenges and Future Directions

Wenrui Wu, Yiu-Wing Kam iD

Vaccines · 16.03.2026 · 14 (3) · 267

DOI: 10.3390/vaccines14030267 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Vaccines, online erschienen am 16.03.2026. Verfasst von Wenrui Wu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Natural and Applied Sciences, Duke Kunshan University, No. 8 Duke Avenue, Kunshan 215316, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oropouche virus (OROV) is an emerging arthropod-borne virus in the Americas that has evolved from a pathogen historically restricted to forest environments into an increasingly important regional and international public health concern. Despite decades of documented circulation, the true burden of OROV infection remains substantially underestimated, largely because of frequent misdiagnosis and the high proportion of asymptomatic or subclinical infections. This review synthesizes current evidence on the historical emergence, epidemiology, transmission dynamics, and clinical features of OROV, with a particular focus on populations at increased risk due to biological susceptibility, environmental exposure, and limited access to healthcare. Drawing on seroepidemiological data, we demonstrate that OROV transmission is far more widespread than routine surveillance suggests and examine how factors such as age, pregnancy, immune status, underlying health conditions, occupational exposure, and healthcare accessibility interact to influence disease risk and detection. Although multiple vaccine platforms have shown promise in preclinical studies, progress toward clinical development remains constrained by limited immunological evidence, shortcomings of available animal models, diagnostic uncertainty, and structural barriers in endemic regions. We propose that future OROV vaccine development prioritize population-specific needs rather than focusing solely on technological platforms, and that effective prevention will require integrating vaccination with strengthened surveillance, improved diagnostics, and equitable delivery systems.

Schlagwörter

Stichwörter der Autor:innen

Oropouche virusarbovirusemerging infectious diseasespublic health surveillancevaccine developmentvulnerable populations

Autor:innen und Institutionen

  • Division of Natural and Applied Sciences, Duke Kunshan University, No. 8 Duke Avenue, Kunshan 215316, China.

ORCID-Profile: Yiu-Wing Kam

Zitieren

APA

Wu, W., & Kam, Y. W. (2026). Oropouche Virus (OROV) Vaccine Development for Vulnerable Populations: Epidemiological Context, Challenges and Future Directions. Vaccines, 14(3), 267. https://doi.org/10.3390/vaccines14030267

Vancouver

Wu W, Kam YW. Oropouche Virus (OROV) Vaccine Development for Vulnerable Populations: Epidemiological Context, Challenges and Future Directions. Vaccines. 2026;14(3):267. doi:10.3390/vaccines14030267

BibTeX
@article{Wu2026,
  author = {Wu, Wenrui and Kam, Yiu-Wing},
  title = {Oropouche Virus (OROV) Vaccine Development for Vulnerable Populations: Epidemiological Context, Challenges and Future Directions},
  journal = {Vaccines},
  year = {2026},
  volume = {14},
  number = {3},
  pages = {267},
  doi = {10.3390/vaccines14030267}
}
Kostenlos starten →